Advertisement
Screener

AbCellera Biologics Inc. (ABCL) ROE

AbCellera Biologics Inc. (ABCL) ROE

  • 2026-06-30: ROE -18.38%.
  • 2026-03-31: ROE -15.35%.
  • 2025-12-31: ROE -15.14%.
  • 2025-09-30: ROE -17.81%.

Complete source-backed roe history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-18.38%
2026-03-31-15.35%
2025-12-31-15.14%
2025-09-30-17.81%
2025-06-30-16.45%
2025-03-31-16.41%
2024-12-31-15.42%
2024-09-30-16.31%
2024-06-30-13.80%
2024-03-31-13.00%
2023-12-31-12.70%
2023-09-30-10.92%
2023-06-30-6.19%
2023-03-31-4.15%
2022-12-3112.85%
2022-09-3019.87%
2022-06-3016.52%
2022-03-3116.96%
2021-12-3114.96%
2021-09-3022.08%
2021-06-3023.69%
2021-03-3124.89%
2020-12-3114.32%

Annual ROE

DateROE
2025-12-31-15.14%
2024-12-31-15.42%
2023-12-31-12.70%
2022-12-3112.85%
2021-12-3114.96%
2020-12-3114.32%
2019-12-31-21.57%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47